Search results
U.S. FDA places hold on Biomea’s diabetes trial
WHTC 1450 Holland· 2 days ago(Reuters) - Biomea Fusion said on Thursday the U.S. Food and Drug Administration had placed a clinical hold on its ongoing early-to-mid stage study of...
Analysis | Weight-loss drugs are so popular they’re headed for Medicare negotiations
Washington Post· 2 days agoToday’s edition: Conservative policymakers with ties to former president Donald Trump want to limit...
Dow Jones Futures: Apple AI Push, Tesla, Fed Loom For Stock Market
Investor's Business Daily· 10 minutes agoBut there are potentially serious side effects. Eli Lilly stock has boomed over the past year...
Ozempic and Wegovy could soon be challenged by China’s generic competitors
Fast Company Magazine· 3 days agoNovo Nordisk is facing the prospect of intensifying competition in the promising Chinese market...
Eli Lilly details NASH effects of weight loss drug (NYSE:LLY)
Seeking Alpha· 4 days agoEli Lilly (LLY) posts detailed mid-stage results highlighting the benefits of its weight loss drug...
Structure Therapeutics reports promising weight-loss drug data | Invezz
Invezz· 6 days agoStructure Therapeutics Inc (NASDAQ: GPCR) is up a whopping 80% on Monday after reporting “compelling” topline data for its weight-loss drug. The biopharmaceutical firm said ...
Drug used to treat eczema may provide relief for patients with intensely itchy skin diseases
Medical Xpress· 3 days agoA drug approved to treat eczema provided significant improvement in the symptoms of patients with severe itching diseases that currently have no targeted treatments, according ...
The race for a weight loss pill heats up as a Novo Nordisk competitor releases new trial results
Quartz· 6 days agoStructure Therapeutics stock jumped 65% to $56 per share on Monday after the biopharmaceutical...
Retrospective Study Based on Electronic Health Rec | Newswise
Newswise· 6 days agoA new study by researchers at the Case Western Reserve University School of Medicine reveals that...
Eli Lilly hits an all-time high. Wall Street handicaps Monday's key Alzheimer's drug meeting
CNBC· 2 days agoEvery weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20...